APO Research
Talk to an analyst

APO RESEARCH · REPORT

Typhoid Vi Polysaccharide Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Typhoid Vi Polysaccharide Vaccine Industry Growth and Trends Forecast to 2032

22 December 202578 pages

Choose your research edition.

Industry ResearchTyphoid Vi Polysaccharide Vaccine Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Typhoid Vi Polysaccharide Vaccine Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Typhoid Vi Polysaccharide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Typhoid Vi Polysaccharide Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Typhoid Vi Polysaccharide Vaccine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Typhoid Vi Polysaccharide Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Typhoid Vi Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Typhoid Vi Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Typhoid Vi Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Typhoid Vi Polysaccharide Vaccine include Sanofi Pasteur SA, GSK and Emergent BioSolutions, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Typhoid Vi Polysaccharide Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Typhoid Vi Polysaccharide Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Typhoid Vi Polysaccharide Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Typhoid Vi Polysaccharide Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Typhoid Vi Polysaccharide Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Typhoid Vi Polysaccharide Vaccine Market by Company

Sanofi Pasteur SA

GSK

Emergent BioSolutions

Typhoid Vi Polysaccharide Vaccine Segment by Type

Child

Adult

Typhoid Vi Polysaccharide Vaccine Segment by Application

Government Institution

Private Sector

Other

Typhoid Vi Polysaccharide Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Typhoid Vi Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Typhoid Vi Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Typhoid Vi Polysaccharide Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Typhoid Vi Polysaccharide Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Typhoid Vi Polysaccharide Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Child Table 2. Major Company of Adult Table 3. Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2021-2026) & (k units) Table 5. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Typhoid Vi Polysaccharide Vaccine Price by Type (2021-2026) & (US$/unit) Table 9. Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2027-2032) & (k units) Table 10. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Typhoid Vi Polysaccharide Vaccine Price by Type (2027-2032) & (US$/unit) Table 14. North America Typhoid Vi Polysaccharide Vaccine Sales by Type (2021-2026) & (k units) Table 15. North America Typhoid Vi Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Typhoid Vi Polysaccharide Vaccine Sales by Type (2021-2026) & (k units) Table 17. Europe Typhoid Vi Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Typhoid Vi Polysaccharide Vaccine Sales by Type (2021-2026) & (k units) Table 21. Latin America Typhoid Vi Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Typhoid Vi Polysaccharide Vaccine Industry Trends Table 25. Typhoid Vi Polysaccharide Vaccine Industry Drivers Table 26. Typhoid Vi Polysaccharide Vaccine Industry Opportunities and Challenges Table 27. Typhoid Vi Polysaccharide Vaccine Industry Restraints Table 28. Global Typhoid Vi Polysaccharide Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Typhoid Vi Polysaccharide Vaccine Sales by Company (2021-2026) & (k units) Table 31. Global Typhoid Vi Polysaccharide Vaccine Sales Share by Company (2021-2026) Table 32. Global Typhoid Vi Polysaccharide Vaccine Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Typhoid Vi Polysaccharide Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Typhoid Vi Polysaccharide Vaccine Major Company Production Sites and Headquarters Table 35. Global Typhoid Vi Polysaccharide Vaccine Company, Product Type & Application Table 36. Global Typhoid Vi Polysaccharide Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Typhoid Vi Polysaccharide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Typhoid Vi Polysaccharide Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Typhoid Vi Polysaccharide Vaccine Sales by Region (2021-2026) & (k units) Table 41. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Typhoid Vi Polysaccharide Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Typhoid Vi Polysaccharide Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Typhoid Vi Polysaccharide Vaccine Sales by Region (2027-2032) & (k units) Table 46. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Typhoid Vi Polysaccharide Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Typhoid Vi Polysaccharide Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2021-2026) & (k units) Table 52. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Typhoid Vi Polysaccharide Vaccine Price by Application (2021-2026) & (US$/unit) Table 56. Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2027-2032) & (k units) Table 57. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Typhoid Vi Polysaccharide Vaccine Price by Application (2027-2032) & (US$/unit) Table 61. North America Typhoid Vi Polysaccharide Vaccine Sales by Application (2021-2026) & (k units) Table 62. North America Typhoid Vi Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Typhoid Vi Polysaccharide Vaccine Sales by Application (2021-2026) & (k units) Table 64. Europe Typhoid Vi Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Typhoid Vi Polysaccharide Vaccine Sales by Application (2021-2026) & (k units) Table 68. Latin America Typhoid Vi Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi Pasteur SA Company Information Table 72. Sanofi Pasteur SA Business Overview Table 73. Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Product Portfolio Table 75. Sanofi Pasteur SA Recent Development Table 76. GSK Company Information Table 77. GSK Business Overview Table 78. GSK Typhoid Vi Polysaccharide Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. GSK Typhoid Vi Polysaccharide Vaccine Product Portfolio Table 80. GSK Recent Development Table 81. Emergent BioSolutions Company Information Table 82. Emergent BioSolutions Business Overview Table 83. Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Product Portfolio Table 85. Emergent BioSolutions Recent Development Table 86. North America Typhoid Vi Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 87. North America Typhoid Vi Polysaccharide Vaccine Sales by Country (2021-2026) & (k units) Table 88. North America Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 89. North America Typhoid Vi Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 90. North America Typhoid Vi Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 91. North America Typhoid Vi Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America Typhoid Vi Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 93. North America Typhoid Vi Polysaccharide Vaccine Market Share by Country (2021-2026) Table 94. North America Typhoid Vi Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America Typhoid Vi Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 96. Europe Typhoid Vi Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 97. Europe Typhoid Vi Polysaccharide Vaccine Sales by Country (2021-2026) & (k units) Table 98. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 99. Europe Typhoid Vi Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 100. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 101. Europe Typhoid Vi Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe Typhoid Vi Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe Typhoid Vi Polysaccharide Vaccine Market Share by Country (2021-2026) Table 104. Europe Typhoid Vi Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe Typhoid Vi Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales by Country (2021-2026) & (k units) Table 108. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 110. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market Share by Country (2021-2026) Table 114. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 116. Latin America Typhoid Vi Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Latin America Typhoid Vi Polysaccharide Vaccine Sales by Country (2021-2026) & (k units) Table 118. Latin America Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 119. Latin America Typhoid Vi Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 120. Latin America Typhoid Vi Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America Typhoid Vi Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America Typhoid Vi Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America Typhoid Vi Polysaccharide Vaccine Market Share by Country (2021-2026) Table 124. Latin America Typhoid Vi Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America Typhoid Vi Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Country (2021-2026) & (k units) Table 128. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 130. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Market Share by Country (2021-2026) Table 134. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Typhoid Vi Polysaccharide Vaccine Distributors List Table 139. Typhoid Vi Polysaccharide Vaccine Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Typhoid Vi Polysaccharide Vaccine Image Figure 2. Global Typhoid Vi Polysaccharide Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Typhoid Vi Polysaccharide Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Typhoid Vi Polysaccharide Vaccine Sales (2021-2032) & (k units) Figure 5. Child Image Figure 6. Global Child Sales YoY Growth (2021-2032) & (k units) Figure 7. Adult Image Figure 8. Global Adult Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Typhoid Vi Polysaccharide Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Typhoid Vi Polysaccharide Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Typhoid Vi Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Typhoid Vi Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Typhoid Vi Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Typhoid Vi Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Typhoid Vi Polysaccharide Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Government Institution Image Figure 24. Global Government Institution Sales YoY Growth (2021-2032) & (k units) Figure 25. Private Sector Image Figure 26. Global Private Sector Sales YoY Growth (2021-2032) & (k units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Typhoid Vi Polysaccharide Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Typhoid Vi Polysaccharide Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America Typhoid Vi Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America Typhoid Vi Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Typhoid Vi Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Typhoid Vi Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America Typhoid Vi Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Typhoid Vi Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Typhoid Vi Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Typhoid Vi Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Typhoid Vi Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Typhoid Vi Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Typhoid Vi Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Typhoid Vi Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Typhoid Vi Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Typhoid Vi Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Typhoid Vi Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Typhoid Vi Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Typhoid Vi Polysaccharide Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Typhoid Vi Polysaccharide Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Child
  • Adult
Applications
  • Government Institution
  • Private Sector
  • Other
Companies covered
  • Sanofi Pasteur SA
  • GSK
  • Emergent BioSolutions

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Typhoid Vi Polysaccharide Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Typhoid Vi Polysaccharide Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Typhoid Vi Polysaccharide Vaccine Market by Type
  6. 1.3.1 Child
  7. 1.3.2 Adult
  8. 1.4 Global Typhoid Vi Polysaccharide Vaccine Market Size by Type
  9. 1.4.1 Global Typhoid Vi Polysaccharide Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Typhoid Vi Polysaccharide Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Typhoid Vi Polysaccharide Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Typhoid Vi Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Typhoid Vi Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Typhoid Vi Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Typhoid Vi Polysaccharide Vaccine Industry Trends
  2. 2.2 Typhoid Vi Polysaccharide Vaccine Industry Drivers
  3. 2.3 Typhoid Vi Polysaccharide Vaccine Industry Opportunities and Challenges
  4. 2.4 Typhoid Vi Polysaccharide Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Typhoid Vi Polysaccharide Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Typhoid Vi Polysaccharide Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Typhoid Vi Polysaccharide Vaccine Price (2021-2026)
  4. 3.4 Global Typhoid Vi Polysaccharide Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Typhoid Vi Polysaccharide Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Typhoid Vi Polysaccharide Vaccine Company, Product Type & Application
  7. 3.7 Global Typhoid Vi Polysaccharide Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Typhoid Vi Polysaccharide Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Typhoid Vi Polysaccharide Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Typhoid Vi Polysaccharide Vaccine Tier 1, Tier 2, and Tier 3
4 Typhoid Vi Polysaccharide Vaccine Regional Status and Outlook
  1. 4.1 Global Typhoid Vi Polysaccharide Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Typhoid Vi Polysaccharide Vaccine Historic Market Size by Region
  3. 4.2.1 Global Typhoid Vi Polysaccharide Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Typhoid Vi Polysaccharide Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Typhoid Vi Polysaccharide Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Typhoid Vi Polysaccharide Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Typhoid Vi Polysaccharide Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Typhoid Vi Polysaccharide Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Typhoid Vi Polysaccharide Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Typhoid Vi Polysaccharide Vaccine by Application
  1. 5.1 Typhoid Vi Polysaccharide Vaccine Market by Application
  2. 5.1.1 Government Institution
  3. 5.1.2 Private Sector
  4. 5.1.3 Other
  5. 5.2 Global Typhoid Vi Polysaccharide Vaccine Market Size by Application
  6. 5.2.1 Global Typhoid Vi Polysaccharide Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Typhoid Vi Polysaccharide Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Typhoid Vi Polysaccharide Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Typhoid Vi Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Typhoid Vi Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Typhoid Vi Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi Pasteur SA
  2. 6.1.1 Sanofi Pasteur SA Company Information
  3. 6.1.2 Sanofi Pasteur SA Business Overview
  4. 6.1.3 Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Product Portfolio
  6. 6.1.5 Sanofi Pasteur SA Recent Developments
  7. 6.2 GSK
  8. 6.2.1 GSK Company Information
  9. 6.2.2 GSK Business Overview
  10. 6.2.3 GSK Typhoid Vi Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GSK Typhoid Vi Polysaccharide Vaccine Product Portfolio
  12. 6.2.5 GSK Recent Developments
  13. 6.3 Emergent BioSolutions
  14. 6.3.1 Emergent BioSolutions Company Information
  15. 6.3.2 Emergent BioSolutions Business Overview
  16. 6.3.3 Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Product Portfolio
  18. 6.3.5 Emergent BioSolutions Recent Developments
7 North America by Country
  1. 7.1 North America Typhoid Vi Polysaccharide Vaccine Sales by Country
  2. 7.1.1 North America Typhoid Vi Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Typhoid Vi Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Typhoid Vi Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Typhoid Vi Polysaccharide Vaccine Market Size by Country
  6. 7.2.1 North America Typhoid Vi Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Typhoid Vi Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Typhoid Vi Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Typhoid Vi Polysaccharide Vaccine Sales by Country
  2. 8.1.1 Europe Typhoid Vi Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Typhoid Vi Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Typhoid Vi Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Typhoid Vi Polysaccharide Vaccine Market Size by Country
  6. 8.2.1 Europe Typhoid Vi Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Typhoid Vi Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Typhoid Vi Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Typhoid Vi Polysaccharide Vaccine Sales by Country
  2. 10.1.1 South America Typhoid Vi Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Typhoid Vi Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Typhoid Vi Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Typhoid Vi Polysaccharide Vaccine Market Size by Country
  6. 10.2.1 South America Typhoid Vi Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Typhoid Vi Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Typhoid Vi Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Typhoid Vi Polysaccharide Vaccine Value Chain Analysis
  2. 12.1.1 Typhoid Vi Polysaccharide Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Typhoid Vi Polysaccharide Vaccine Production Mode & Process
  7. 12.2 Typhoid Vi Polysaccharide Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Typhoid Vi Polysaccharide Vaccine Distributors
  10. 12.2.3 Typhoid Vi Polysaccharide Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst